Evidence map›Paper›PMID 40214897›Full record

ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2025

Lights and Shadows of Bariatric Surgery: Insights from a Nationwide Administrative Database of People Living with Type 1 Diabetes and Obesity.

Claire Carette, Claire Rives-Lange, Nicholas Shoung, Aurélie Phan, Elodie Torreton, Anne Dutour, Bruno Detournay, Sébastien Czernichow

Abstract read
In one paragraph

Article in Diabetes therapy : research, treatment and education of diabetes and related disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Claire CaretteNutrition Department, Assistance Publique-Hôpitaux de Paris (AP-HP), Georges-Pompidou European Hospital, 20 Rue Leblanc, 75015, Paris, France. claire.carette@aphp.fr.ORCID http://orcid.org/0000-0002-8175-0369
Claire Rives-LangeNutrition Department, Assistance Publique-Hôpitaux de Paris (AP-HP), Georges-Pompidou European Hospital, 20 Rue Leblanc, 75015, Paris, France.
Nicholas ShoungNutrition Department, Assistance Publique-Hôpitaux de Paris (AP-HP), Georges-Pompidou European Hospital, 20 Rue Leblanc, 75015, Paris, France.
Aurélie PhanNutrition Department, Assistance Publique-Hôpitaux de Paris (AP-HP), Georges-Pompidou European Hospital, 20 Rue Leblanc, 75015, Paris, France.
Elodie TorretonCEMKA, Bourg-la-Reine, France.
Anne DutourAix Marseille University, INSERM, INRAE, C2VN, Marseille, France.
Bruno DetournayCEMKA, Bourg-la-Reine, France.
Sébastien CzernichowNutrition Department, Assistance Publique-Hôpitaux de Paris (AP-HP), Georges-Pompidou European Hospital, 20 Rue Leblanc, 75015, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe study aimed to describe the population of patients living with type 1 diabetes who had access to bariatric surgery (BS) in France, analyzing the changes in healthcare resource use and associated costs in the 3 years following this surgery.

methodsAn observational longitudinal study based on the French national health insurance database was conducted on all adult patients that underwent a first BS from 2015 to 2020. Cost analyses were conducted on a sub-population who underwent BS from 2016 to 2017 for sufficient observation time using a pre-post methodology.

resultsA total of 437 patients were identified as living with type 1 diabetes among the 234,077 patients who had undergone surgery over 6 years (2015-2020). The most frequently performed interventions were sleeve gastrectomy (n = 272; 62.2%) and gastric bypass (n = 154; 35.2%), with the majority of patients being women (77.8%) and an average age of 42.3 (± 12.0) years, consistent with the general population undergoing BS in France. While no significant differences were found in the overall healthcare costs when comparing the 3 years before and after BS, there was an increase in the frequency of biological measurements. Expenditures related to antidiabetic medications and insulin decreased significantly (p < 0.0001). The number of hospitalizations for severe hypoglycemia, coma, and ketoacidosis more than doubled in the 3 years following surgery compared with the period before (p = 0.04).

conclusionsThe risks of severe hypoglycemia or ketoacidosis in patients with type 1 diabetes undergoing BS remains a real concern and emphasizes the importance of involving the diabetologist in the operative decision with joint follow-up with the nutritionist.

Indexed as

Bariatric surgeryHypoglycemiaInsulinKetoacidosisType 1 diabetes

Identifiers

PMID40214897
PMCPMC12085492

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.